Kevin Lee Freeman insider trades
Open-market stock purchases and sales by Kevin Lee Freeman, Chief Commercial Officer at Health Catalyst, Inc, from SEC Form 4 filings since Sep 8, 2022.
Recent trades
| Date | Stock | Trade | Value |
|---|---|---|---|
| Dec 1, 2025 | HCAT Health Catalyst, Inc | Sold (not open market) | $47.6K |
Companies traded
- HCAT Health Catalyst, Inc: 3 sales, last Dec 1, 2025